Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /manage Disallow: /bbpe Disallow: /public/lineBot Disallow: /*/act/ Disallow: |
Title | 研生生醫股份有限公司 |
Description | About 研生生醫股份有限公司AcadeMab Biomedical Inc. (以下簡稱研生生醫 |
Keywords | 抗體新藥 |
WebSite | academab.com |
Host IP | 103.136.60.142 |
Location | - |
Site | Rank |
US$1,592
Last updated: 2023-05-19 18:33:46
academab.com has Semrush global rank of 0. academab.com has an estimated worth of US$ 1,592, based on its estimated Ads revenue. academab.com receives approximately 183 unique visitors each day. Its web server is located in -, with IP address 103.136.60.142. According to SiteAdvisor, academab.com is safe to visit. |
Purchase/Sale Value | US$1,592 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$44 |
Yearly Ads Revenue | US$529 |
Daily Unique Visitors | 12 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
academab.com. | A | 600 | IP: 103.136.60.142 |
academab.com. | NS | 3600 | NS Record: ns43.domaincontrol.com. |
academab.com. | NS | 3600 | NS Record: ns44.domaincontrol.com. |
academab.com. | MX | 3600 | MX Record: 0 academab-com.mail.protection.outlook.com. |
academab.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
academab.com. | TXT | 3600 | TXT Record: v=verifydomain MS=7257817 |
academab.com. | TXT | 3600 | TXT Record: google-site-verification=W1ehtGJK3CW7MVS9iEQaobISH8ptBYfWLrErePWwDUY |
研生生醫股份有限公司 About Us pipeline technology News Contact Us EN TW Break new ground for a healthier, longer life 1 1 SCROLL DOWN 2023/03/06 研生精準醫療抗體新藥AM-928取得美國IND 對多種癌症治療具臨床潛力 more 2022/08/09 AcadeMab focusing on COVID-19 antibody drug more 2022/07/13 後疫情時代抗體藥物開發策略(直接影片) more 2022/07/13 Taiwan’s AcadeMab develops groundbreaking therapy for COVID-19 Omicron variant with potent neutralizing efficacy more 2022/06/22 AcadeMab makes its mark at 2022 BIO USA more About Us We have multiple proprietary cutting-edge technology platforms to develop high-quality, competitive first-in-class or best-in-class new antibody drugs. more pipeline AM-928 (Anti-EpCAM mAb) Epithelial cell adhesion molecule (EpCAM) is a highly expressed antigen in various solid tumors including, colorectal, gastric, head and neck and ovarian cancers, which holds a critical position in tumor progression process. SB-001 (Anti-COVID-19 mAb) AcadeMab has discovered a panel of fully human monoclonal antibodies (mAbs) directly |
HTTP/1.1 301 Moved Permanently Server: nginx Date: Wed, 09 Nov 2022 08:23:11 GMT Content-Type: text/html Content-Length: 162 Connection: keep-alive Location: https://academab.com/ X-Frame-Options: SAMEORIGIN X-Content-Type-Options: nosniff X-XSS-Protection: 1; mode=block HTTP/2 301 server: nginx date: Wed, 09 Nov 2022 08:23:12 GMT content-type: text/html; charset=iso-8859-1 x-frame-options: SAMEORIGIN location: https://www.academab.com/ x-frame-options: SAMEORIGIN x-content-type-options: nosniff x-xss-protection: 1; mode=block HTTP/2 200 server: nginx date: Wed, 09 Nov 2022 08:23:14 GMT content-type: text/html; charset=utf-8 vary: Accept-Encoding x-frame-options: sameorigin, SAMEORIGIN x-content-type-options: nosniff x-xss-protection: 1; mode=block expires: Thu, 19 Nov 1981 08:52:00 GMT cache-control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0 pragma: no-cache set-cookie: PHPSESSID=a2c3c54714fe47d54328d23c4c21969c; path=/; domain=www.academab.com; HttpOnly; SameSite=Lax x-content-type-options: nosniff x-xss-protection: 1; mode=block x-frame-options: SAMEORIGIN x-content-type-options: nosniff x-xss-protection: 1; mode=block |
Domain Name: ACADEMAB.COM Registry Domain ID: 2572889729_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2022-10-31T22:34:57Z Creation Date: 2020-11-17T08:31:09Z Registry Expiry Date: 2030-11-17T08:31:09Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS43.DOMAINCONTROL.COM Name Server: NS44.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-11-09T08:20:41Z <<< |